Ex Vivo Generation of Human Anti–Pre-B Leukemia-Specific Autologous Cytolytic T Cells
Authors:
Open Access
- 15 July 1997
- journal article
- Published by American Society of Hematology in Blood
- Vol. 90 (2) , 549-561
Abstract
In contrast to other neoplasms, antigen-specific autologous cytolytic T cells have not been detected in patients with human pre-B–cell leukemias. The absence of efficient B7 family (B7-1/CD80; B7-2/CD86) -mediated costimulation has been shown to be a major defect in tumor cells' capacity to function as antigen-presenting cells. We show here the generation of autologous anti–pre-B–cell leukemia-specific cytolytic T-cell lines from the marrows of 10 of 15 patients with pre-B–cell malignancies. T-cell costimulation via CD28 is an absolute requirement for the generation of these autologous cytolytic T cells (CTL). Although costimulation could be delivered by either bystander B7 transfectants or professional antigen-presenting cells (indirect costimulation), optimal priming and CTL expansion required that the costimulatory signal was expressed by the tumor cell (direct costimulation). These anti–pre-B–cell leukemia-specific CTL lysed both unstimulated and CD40-stimulated tumor cells from each patient studied but did not lyse either K562 or CD40-stimulated allogeneic B cells. Cytolysis was mediated by the induction of tumor cell apoptosis by CD8+ T cells via the perforin-granzyme pathway. Although we were able to generate anti–leukemia-specific CTL from the bone marrow, we were unable to generate such CTL from the peripheral blood of these patients. These studies show that antigen-specific CTL can be generated from the bone marrow of patients with pre-B–cell leukemias and these findings should facilitate the design of adoptive T-cell–mediated immunotherapy trials for the treatment of patients with B-cell precursor malignancies.Keywords
This publication has 30 references indexed in Scilit:
- The critical role of CD28 signalling in the prevention of human T-cell anergyResearch in Immunology, 1995
- Tumor Cells Expressing Major Histocompatibility Complex Class II and B7 Activation Molecules Stimulate Potent Tumor-Specific ImmunityJournal of Immunotherapy, 1993
- Soluble CD40 ligand can replace the normal T cell-derived CD40 ligand signal to B cells in T cell-dependent activation.Journal of Experimental Medicine, 1993
- Generation of leukemia-reactive cytotoxic T lymphocyte clones from the HLA-identical bone marrow donor of a patient with leukemia.Journal of Experimental Medicine, 1992
- MHC class‐I‐restricted auto‐tumor‐specific CD4+CD8 −T‐cell clones established from autologous mixed lymphocyte‐tumor‐cell culture (MLTC)International Journal of Cancer, 1992
- Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies.Journal of Experimental Medicine, 1992
- Clonal analysis of cytotoxic T cell response against human melanoma.Journal of Experimental Medicine, 1983
- Alloreactive cloned T cell lines. I. Interactions between cloned amplifier and cytolytic T cell lines.Journal of Experimental Medicine, 1980
- Distinct Ir genes for helper and killer cells in the cytotoxic response to H-Y antigen.Journal of Experimental Medicine, 1979
- T-cell lines which cooperate in generation of specific cytolytic activityNature, 1979